nodes	percent_of_prediction	percent_of_DWPC	metapath
Alimemazine—CYP3A4—Topotecan—lung cancer	0.109	0.142	CbGbCtD
Alimemazine—CYP3A4—Gefitinib—lung cancer	0.0994	0.13	CbGbCtD
Alimemazine—CYP3A4—Teniposide—lung cancer	0.0964	0.126	CbGbCtD
Alimemazine—CYP3A4—Vinorelbine—lung cancer	0.0766	0.1	CbGbCtD
Alimemazine—CYP3A4—Crizotinib—lung cancer	0.0609	0.0796	CbGbCtD
Alimemazine—CYP3A4—Erlotinib—lung cancer	0.0588	0.0768	CbGbCtD
Alimemazine—CYP3A4—Paclitaxel—lung cancer	0.0538	0.0703	CbGbCtD
Alimemazine—CYP3A4—Irinotecan—lung cancer	0.0531	0.0694	CbGbCtD
Alimemazine—CYP3A4—Vinblastine—lung cancer	0.0472	0.0617	CbGbCtD
Alimemazine—CYP3A4—Etoposide—lung cancer	0.0425	0.0556	CbGbCtD
Alimemazine—CYP3A4—Docetaxel—lung cancer	0.0389	0.0508	CbGbCtD
Alimemazine—CYP3A4—Doxorubicin—lung cancer	0.029	0.0379	CbGbCtD
Alimemazine—Arrhythmia supraventricular—Pemetrexed—lung cancer	0.0134	0.0648	CcSEcCtD
Alimemazine—Arrhythmia supraventricular—Gemcitabine—lung cancer	0.00551	0.0267	CcSEcCtD
Alimemazine—Ventricular tachycardia—Pemetrexed—lung cancer	0.00518	0.0251	CcSEcCtD
Alimemazine—Pallor—Teniposide—lung cancer	0.00506	0.0245	CcSEcCtD
Alimemazine—Electrocardiogram ST segment depression—Doxorubicin—lung cancer	0.00417	0.0202	CcSEcCtD
Alimemazine—Akathisia—Irinotecan—lung cancer	0.00396	0.0192	CcSEcCtD
Alimemazine—Hypokalaemia—Crizotinib—lung cancer	0.00374	0.0181	CcSEcCtD
Alimemazine—Hypokalaemia—Gefitinib—lung cancer	0.0034	0.0165	CcSEcCtD
Alimemazine—Agranulocytosis—Pemetrexed—lung cancer	0.0027	0.0131	CcSEcCtD
Alimemazine—Cardiac disorder—Crizotinib—lung cancer	0.00264	0.0128	CcSEcCtD
Alimemazine—Arrhythmia—Crizotinib—lung cancer	0.00254	0.0123	CcSEcCtD
Alimemazine—Cardiac disorder—Gefitinib—lung cancer	0.0024	0.0116	CcSEcCtD
Alimemazine—Arrhythmia—Pemetrexed—lung cancer	0.00232	0.0113	CcSEcCtD
Alimemazine—Arrhythmia—Gefitinib—lung cancer	0.00231	0.0112	CcSEcCtD
Alimemazine—Hypokalaemia—Erlotinib—lung cancer	0.00203	0.00985	CcSEcCtD
Alimemazine—Infection—Crizotinib—lung cancer	0.00201	0.00974	CcSEcCtD
Alimemazine—Nervous system disorder—Crizotinib—lung cancer	0.00198	0.00961	CcSEcCtD
Alimemazine—Dyskinesia—Paclitaxel—lung cancer	0.0019	0.00923	CcSEcCtD
Alimemazine—Arrhythmia—Teniposide—lung cancer	0.00188	0.00912	CcSEcCtD
Alimemazine—Dry mouth—Gefitinib—lung cancer	0.00187	0.00908	CcSEcCtD
Alimemazine—Atrioventricular block—Paclitaxel—lung cancer	0.00184	0.00894	CcSEcCtD
Alimemazine—Infection—Pemetrexed—lung cancer	0.00183	0.0089	CcSEcCtD
Alimemazine—Infection—Gefitinib—lung cancer	0.00182	0.00884	CcSEcCtD
Alimemazine—Nervous system disorder—Pemetrexed—lung cancer	0.00181	0.00878	CcSEcCtD
Alimemazine—Nervous system disorder—Gefitinib—lung cancer	0.0018	0.00873	CcSEcCtD
Alimemazine—Ventricular tachycardia—Paclitaxel—lung cancer	0.00179	0.00867	CcSEcCtD
Alimemazine—Amenorrhoea—Docetaxel—lung cancer	0.00173	0.00837	CcSEcCtD
Alimemazine—Hypotension—Gefitinib—lung cancer	0.00171	0.00832	CcSEcCtD
Alimemazine—Agitation—Teniposide—lung cancer	0.00168	0.00817	CcSEcCtD
Alimemazine—Agranulocytosis—Vinblastine—lung cancer	0.00167	0.0081	CcSEcCtD
Alimemazine—Body temperature increased—Crizotinib—lung cancer	0.0016	0.00775	CcSEcCtD
Alimemazine—Nasal congestion—Cisplatin—lung cancer	0.00159	0.00769	CcSEcCtD
Alimemazine—Infection—Teniposide—lung cancer	0.00149	0.00721	CcSEcCtD
Alimemazine—Body temperature increased—Pemetrexed—lung cancer	0.00146	0.00708	CcSEcCtD
Alimemazine—Orthostatic hypotension—Irinotecan—lung cancer	0.00145	0.00705	CcSEcCtD
Alimemazine—Body temperature increased—Gefitinib—lung cancer	0.00145	0.00704	CcSEcCtD
Alimemazine—Hypokalaemia—Irinotecan—lung cancer	0.00145	0.00703	CcSEcCtD
Alimemazine—Nasal congestion—Paclitaxel—lung cancer	0.00142	0.00691	CcSEcCtD
Alimemazine—Hypokalaemia—Gemcitabine—lung cancer	0.00141	0.00684	CcSEcCtD
Alimemazine—Hypotension—Teniposide—lung cancer	0.0014	0.00678	CcSEcCtD
Alimemazine—Agranulocytosis—Vinorelbine—lung cancer	0.00139	0.00673	CcSEcCtD
Alimemazine—Arrhythmia—Erlotinib—lung cancer	0.00138	0.00669	CcSEcCtD
Alimemazine—Orthostatic hypotension—Cisplatin—lung cancer	0.00132	0.0064	CcSEcCtD
Alimemazine—Hypokalaemia—Cisplatin—lung cancer	0.00132	0.00638	CcSEcCtD
Alimemazine—Rash—Crizotinib—lung cancer	0.00127	0.00618	CcSEcCtD
Alimemazine—Dermatitis—Crizotinib—lung cancer	0.00127	0.00617	CcSEcCtD
Alimemazine—Cardiac disorder—Vinorelbine—lung cancer	0.00124	0.00601	CcSEcCtD
Alimemazine—Convulsion—Vinblastine—lung cancer	0.00121	0.00588	CcSEcCtD
Alimemazine—Jaundice—Irinotecan—lung cancer	0.0012	0.0058	CcSEcCtD
Alimemazine—Arrhythmia—Vinorelbine—lung cancer	0.00119	0.00578	CcSEcCtD
Alimemazine—Orthostatic hypotension—Paclitaxel—lung cancer	0.00119	0.00575	CcSEcCtD
Alimemazine—Body temperature increased—Teniposide—lung cancer	0.00118	0.00574	CcSEcCtD
Alimemazine—Hypokalaemia—Paclitaxel—lung cancer	0.00118	0.00573	CcSEcCtD
Alimemazine—Rash—Pemetrexed—lung cancer	0.00116	0.00565	CcSEcCtD
Alimemazine—Dermatitis—Pemetrexed—lung cancer	0.00116	0.00564	CcSEcCtD
Alimemazine—Rash—Gefitinib—lung cancer	0.00116	0.00561	CcSEcCtD
Alimemazine—Dermatitis—Gefitinib—lung cancer	0.00116	0.00561	CcSEcCtD
Alimemazine—Agranulocytosis—Gemcitabine—lung cancer	0.00111	0.00541	CcSEcCtD
Alimemazine—Infection—Topotecan—lung cancer	0.0011	0.00534	CcSEcCtD
Alimemazine—Infection—Erlotinib—lung cancer	0.00109	0.00529	CcSEcCtD
Alimemazine—Nervous system disorder—Topotecan—lung cancer	0.00109	0.00527	CcSEcCtD
Alimemazine—Amenorrhoea—Doxorubicin—lung cancer	0.00108	0.00522	CcSEcCtD
Alimemazine—Jaundice cholestatic—Doxorubicin—lung cancer	0.00108	0.00522	CcSEcCtD
Alimemazine—Nervous system disorder—Erlotinib—lung cancer	0.00108	0.00522	CcSEcCtD
Alimemazine—Photosensitivity reaction—Paclitaxel—lung cancer	0.00102	0.00497	CcSEcCtD
Alimemazine—Cardiac disorder—Irinotecan—lung cancer	0.00102	0.00496	CcSEcCtD
Alimemazine—Dyskinesia—Doxorubicin—lung cancer	0.00101	0.00488	CcSEcCtD
Alimemazine—Orthostatic hypotension—Docetaxel—lung cancer	0.001	0.00487	CcSEcCtD
Alimemazine—Cardiac disorder—Gemcitabine—lung cancer	0.000995	0.00483	CcSEcCtD
Alimemazine—Jaundice—Etoposide—lung cancer	0.000994	0.00482	CcSEcCtD
Alimemazine—Insomnia—Erlotinib—lung cancer	0.000992	0.00481	CcSEcCtD
Alimemazine—Arrhythmia—Irinotecan—lung cancer	0.000984	0.00477	CcSEcCtD
Alimemazine—Gynaecomastia—Methotrexate—lung cancer	0.000977	0.00474	CcSEcCtD
Alimemazine—Atrioventricular block—Doxorubicin—lung cancer	0.000975	0.00473	CcSEcCtD
Alimemazine—Arrhythmia—Gemcitabine—lung cancer	0.000958	0.00465	CcSEcCtD
Alimemazine—Agranulocytosis—Etoposide—lung cancer	0.000952	0.00462	CcSEcCtD
Alimemazine—Ventricular tachycardia—Doxorubicin—lung cancer	0.000946	0.00459	CcSEcCtD
Alimemazine—Rash—Teniposide—lung cancer	0.000943	0.00457	CcSEcCtD
Alimemazine—Dermatitis—Teniposide—lung cancer	0.000942	0.00457	CcSEcCtD
Alimemazine—Infection—Vinorelbine—lung cancer	0.000942	0.00457	CcSEcCtD
Alimemazine—Nervous system disorder—Vinorelbine—lung cancer	0.00093	0.00451	CcSEcCtD
Alimemazine—Cardiac disorder—Cisplatin—lung cancer	0.000928	0.0045	CcSEcCtD
Alimemazine—Photosensitivity—Methotrexate—lung cancer	0.000903	0.00438	CcSEcCtD
Alimemazine—Arrhythmia—Cisplatin—lung cancer	0.000893	0.00433	CcSEcCtD
Alimemazine—Hypotension—Vinorelbine—lung cancer	0.000886	0.0043	CcSEcCtD
Alimemazine—Body temperature increased—Topotecan—lung cancer	0.000877	0.00425	CcSEcCtD
Alimemazine—Body temperature increased—Erlotinib—lung cancer	0.000867	0.00421	CcSEcCtD
Alimemazine—Cardiac disorder—Etoposide—lung cancer	0.00085	0.00412	CcSEcCtD
Alimemazine—Cardiac disorder—Paclitaxel—lung cancer	0.000833	0.00404	CcSEcCtD
Alimemazine—Jaundice—Docetaxel—lung cancer	0.000826	0.00401	CcSEcCtD
Alimemazine—Tremor—Cisplatin—lung cancer	0.000815	0.00395	CcSEcCtD
Alimemazine—Arrhythmia—Paclitaxel—lung cancer	0.000802	0.00389	CcSEcCtD
Alimemazine—Agranulocytosis—Docetaxel—lung cancer	0.000791	0.00384	CcSEcCtD
Alimemazine—Photosensitivity—Doxorubicin—lung cancer	0.000782	0.00379	CcSEcCtD
Alimemazine—Infection—Irinotecan—lung cancer	0.000777	0.00377	CcSEcCtD
Alimemazine—Nervous system disorder—Irinotecan—lung cancer	0.000767	0.00372	CcSEcCtD
Alimemazine—Infection—Gemcitabine—lung cancer	0.000757	0.00367	CcSEcCtD
Alimemazine—Convulsion—Cisplatin—lung cancer	0.000754	0.00366	CcSEcCtD
Alimemazine—Body temperature increased—Vinorelbine—lung cancer	0.00075	0.00364	CcSEcCtD
Alimemazine—Nervous system disorder—Gemcitabine—lung cancer	0.000747	0.00362	CcSEcCtD
Alimemazine—Clomipramine—GSTP1—lung cancer	0.000742	0.0971	CrCbGaD
Alimemazine—Tremor—Paclitaxel—lung cancer	0.000732	0.00355	CcSEcCtD
Alimemazine—Hypotension—Irinotecan—lung cancer	0.000731	0.00355	CcSEcCtD
Alimemazine—Agitation—Paclitaxel—lung cancer	0.000718	0.00348	CcSEcCtD
Alimemazine—Hypotension—Gemcitabine—lung cancer	0.000712	0.00345	CcSEcCtD
Alimemazine—Insomnia—Irinotecan—lung cancer	0.000708	0.00343	CcSEcCtD
Alimemazine—Cardiac disorder—Docetaxel—lung cancer	0.000706	0.00343	CcSEcCtD
Alimemazine—Infection—Cisplatin—lung cancer	0.000706	0.00342	CcSEcCtD
Alimemazine—Rash—Topotecan—lung cancer	0.000699	0.00339	CcSEcCtD
Alimemazine—Dermatitis—Topotecan—lung cancer	0.000698	0.00339	CcSEcCtD
Alimemazine—Nervous system disorder—Cisplatin—lung cancer	0.000697	0.00338	CcSEcCtD
Alimemazine—Rash—Erlotinib—lung cancer	0.000692	0.00335	CcSEcCtD
Alimemazine—Dermatitis—Erlotinib—lung cancer	0.000691	0.00335	CcSEcCtD
Alimemazine—Convulsion—Etoposide—lung cancer	0.000691	0.00335	CcSEcCtD
Alimemazine—Insomnia—Gemcitabine—lung cancer	0.000689	0.00334	CcSEcCtD
Alimemazine—Arrhythmia—Docetaxel—lung cancer	0.00068	0.0033	CcSEcCtD
Alimemazine—Eosinophilia—Methotrexate—lung cancer	0.000679	0.00329	CcSEcCtD
Alimemazine—Convulsion—Paclitaxel—lung cancer	0.000677	0.00328	CcSEcCtD
Alimemazine—Hypotension—Cisplatin—lung cancer	0.000664	0.00322	CcSEcCtD
Alimemazine—Dry mouth—Paclitaxel—lung cancer	0.000651	0.00316	CcSEcCtD
Alimemazine—Infection—Etoposide—lung cancer	0.000646	0.00314	CcSEcCtD
Alimemazine—Infection—Paclitaxel—lung cancer	0.000634	0.00307	CcSEcCtD
Alimemazine—Erectile dysfunction—Methotrexate—lung cancer	0.000631	0.00306	CcSEcCtD
Alimemazine—Orthostatic hypotension—Doxorubicin—lung cancer	0.000627	0.00304	CcSEcCtD
Alimemazine—Nervous system disorder—Paclitaxel—lung cancer	0.000626	0.00303	CcSEcCtD
Alimemazine—Photosensitivity reaction—Methotrexate—lung cancer	0.000626	0.00303	CcSEcCtD
Alimemazine—Hypokalaemia—Doxorubicin—lung cancer	0.000625	0.00303	CcSEcCtD
Alimemazine—Body temperature increased—Irinotecan—lung cancer	0.000618	0.003	CcSEcCtD
Alimemazine—Hypotension—Etoposide—lung cancer	0.000608	0.00295	CcSEcCtD
Alimemazine—Body temperature increased—Gemcitabine—lung cancer	0.000602	0.00292	CcSEcCtD
Alimemazine—Rash—Vinorelbine—lung cancer	0.000598	0.0029	CcSEcCtD
Alimemazine—Dermatitis—Vinorelbine—lung cancer	0.000598	0.0029	CcSEcCtD
Alimemazine—Hypotension—Paclitaxel—lung cancer	0.000596	0.00289	CcSEcCtD
Alimemazine—Eosinophilia—Doxorubicin—lung cancer	0.000588	0.00285	CcSEcCtD
Alimemazine—Insomnia—Paclitaxel—lung cancer	0.000577	0.0028	CcSEcCtD
Alimemazine—Convulsion—Docetaxel—lung cancer	0.000574	0.00278	CcSEcCtD
Alimemazine—Agranulocytosis—Methotrexate—lung cancer	0.00057	0.00277	CcSEcCtD
Alimemazine—Body temperature increased—Cisplatin—lung cancer	0.000561	0.00272	CcSEcCtD
Alimemazine—Dry mouth—Docetaxel—lung cancer	0.000552	0.00268	CcSEcCtD
Alimemazine—Photosensitivity reaction—Doxorubicin—lung cancer	0.000542	0.00263	CcSEcCtD
Alimemazine—Infection—Docetaxel—lung cancer	0.000537	0.00261	CcSEcCtD
Alimemazine—Nervous system disorder—Docetaxel—lung cancer	0.00053	0.00257	CcSEcCtD
Alimemazine—Jaundice—Doxorubicin—lung cancer	0.000516	0.0025	CcSEcCtD
Alimemazine—Body temperature increased—Etoposide—lung cancer	0.000514	0.00249	CcSEcCtD
Alimemazine—Cardiac disorder—Methotrexate—lung cancer	0.000509	0.00247	CcSEcCtD
Alimemazine—Hypotension—Docetaxel—lung cancer	0.000505	0.00245	CcSEcCtD
Alimemazine—Body temperature increased—Paclitaxel—lung cancer	0.000504	0.00245	CcSEcCtD
Alimemazine—Agranulocytosis—Doxorubicin—lung cancer	0.000494	0.00239	CcSEcCtD
Alimemazine—Rash—Irinotecan—lung cancer	0.000493	0.00239	CcSEcCtD
Alimemazine—Dermatitis—Irinotecan—lung cancer	0.000493	0.00239	CcSEcCtD
Alimemazine—Insomnia—Docetaxel—lung cancer	0.000489	0.00237	CcSEcCtD
Alimemazine—Rash—Gemcitabine—lung cancer	0.00048	0.00233	CcSEcCtD
Alimemazine—Dermatitis—Gemcitabine—lung cancer	0.00048	0.00233	CcSEcCtD
Alimemazine—Rash—Cisplatin—lung cancer	0.000448	0.00217	CcSEcCtD
Alimemazine—Dermatitis—Cisplatin—lung cancer	0.000447	0.00217	CcSEcCtD
Alimemazine—Cardiac disorder—Doxorubicin—lung cancer	0.000441	0.00214	CcSEcCtD
Alimemazine—Desipramine—CYP2A6—lung cancer	0.000431	0.0564	CrCbGaD
Alimemazine—Body temperature increased—Docetaxel—lung cancer	0.000427	0.00207	CcSEcCtD
Alimemazine—Arrhythmia—Doxorubicin—lung cancer	0.000424	0.00206	CcSEcCtD
Alimemazine—Convulsion—Methotrexate—lung cancer	0.000414	0.00201	CcSEcCtD
Alimemazine—Rash—Etoposide—lung cancer	0.00041	0.00199	CcSEcCtD
Alimemazine—Dermatitis—Etoposide—lung cancer	0.00041	0.00199	CcSEcCtD
Alimemazine—Rash—Paclitaxel—lung cancer	0.000402	0.00195	CcSEcCtD
Alimemazine—Dermatitis—Paclitaxel—lung cancer	0.000402	0.00195	CcSEcCtD
Alimemazine—Infection—Methotrexate—lung cancer	0.000387	0.00188	CcSEcCtD
Alimemazine—Nervous system disorder—Methotrexate—lung cancer	0.000382	0.00185	CcSEcCtD
Alimemazine—Agitation—Doxorubicin—lung cancer	0.00038	0.00184	CcSEcCtD
Alimemazine—Hypotension—Methotrexate—lung cancer	0.000364	0.00177	CcSEcCtD
Alimemazine—Oxcarbazepine—ALB—lung cancer	0.000364	0.0476	CrCbGaD
Alimemazine—Thioridazine—CYP2E1—lung cancer	0.000358	0.0469	CrCbGaD
Alimemazine—Convulsion—Doxorubicin—lung cancer	0.000358	0.00174	CcSEcCtD
Alimemazine—Insomnia—Methotrexate—lung cancer	0.000353	0.00171	CcSEcCtD
Alimemazine—Dry mouth—Doxorubicin—lung cancer	0.000344	0.00167	CcSEcCtD
Alimemazine—Methotrimeprazine—CYP2E1—lung cancer	0.000342	0.0448	CrCbGaD
Alimemazine—Rash—Docetaxel—lung cancer	0.000341	0.00165	CcSEcCtD
Alimemazine—Dermatitis—Docetaxel—lung cancer	0.000341	0.00165	CcSEcCtD
Alimemazine—Infection—Doxorubicin—lung cancer	0.000335	0.00163	CcSEcCtD
Alimemazine—Nervous system disorder—Doxorubicin—lung cancer	0.000331	0.00161	CcSEcCtD
Alimemazine—Orphenadrine—CYP2E1—lung cancer	0.000325	0.0426	CrCbGaD
Alimemazine—Diltiazem—ABCB1—lung cancer	0.000318	0.0417	CrCbGaD
Alimemazine—Hypotension—Doxorubicin—lung cancer	0.000315	0.00153	CcSEcCtD
Alimemazine—Body temperature increased—Methotrexate—lung cancer	0.000308	0.00149	CcSEcCtD
Alimemazine—Desipramine—CYP2E1—lung cancer	0.000306	0.0401	CrCbGaD
Alimemazine—Insomnia—Doxorubicin—lung cancer	0.000305	0.00148	CcSEcCtD
Alimemazine—Triflupromazine—ABCB1—lung cancer	0.000284	0.0371	CrCbGaD
Alimemazine—Acepromazine—ALB—lung cancer	0.000275	0.036	CrCbGaD
Alimemazine—Thioproperazine—ALB—lung cancer	0.000269	0.0352	CrCbGaD
Alimemazine—Body temperature increased—Doxorubicin—lung cancer	0.000267	0.00129	CcSEcCtD
Alimemazine—Pipotiazine—ALB—lung cancer	0.000264	0.0346	CrCbGaD
Alimemazine—Chlorpromazine—CYP2E1—lung cancer	0.000261	0.0342	CrCbGaD
Alimemazine—Imipramine—CYP2E1—lung cancer	0.00026	0.034	CrCbGaD
Alimemazine—Amitriptyline—CYP2E1—lung cancer	0.000258	0.0338	CrCbGaD
Alimemazine—Rash—Methotrexate—lung cancer	0.000246	0.00119	CcSEcCtD
Alimemazine—Dermatitis—Methotrexate—lung cancer	0.000246	0.00119	CcSEcCtD
Alimemazine—Carbamazepine—ABCB1—lung cancer	0.000237	0.031	CrCbGaD
Alimemazine—Rash—Doxorubicin—lung cancer	0.000213	0.00103	CcSEcCtD
Alimemazine—Dermatitis—Doxorubicin—lung cancer	0.000213	0.00103	CcSEcCtD
Alimemazine—Clomipramine—ALB—lung cancer	0.000209	0.0274	CrCbGaD
Alimemazine—Clomipramine—ABCB1—lung cancer	0.0002	0.0261	CrCbGaD
Alimemazine—Chlorprothixene—ABCB1—lung cancer	0.000199	0.026	CrCbGaD
Alimemazine—Trimipramine—ABCB1—lung cancer	0.000184	0.024	CrCbGaD
Alimemazine—Promethazine—ABCB1—lung cancer	0.000177	0.0231	CrCbGaD
Alimemazine—Doxepin—ABCB1—lung cancer	0.000175	0.0229	CrCbGaD
Alimemazine—Trifluoperazine—ABCB1—lung cancer	0.000174	0.0228	CrCbGaD
Alimemazine—Methadone—ABCB1—lung cancer	0.000174	0.0228	CrCbGaD
Alimemazine—Desipramine—ABCB1—lung cancer	0.000161	0.021	CrCbGaD
Alimemazine—Chlorpromazine—ALB—lung cancer	0.000143	0.0188	CrCbGaD
Alimemazine—Amitriptyline—ALB—lung cancer	0.000142	0.0186	CrCbGaD
Alimemazine—Chlorpromazine—ABCB1—lung cancer	0.000137	0.0179	CrCbGaD
Alimemazine—Imipramine—ABCB1—lung cancer	0.000136	0.0178	CrCbGaD
Alimemazine—Amitriptyline—ABCB1—lung cancer	0.000135	0.0177	CrCbGaD
Alimemazine—HRH1—Class A/1 (Rhodopsin-like receptors)—OXTR—lung cancer	9.4e-05	0.00452	CbGpPWpGaD
Alimemazine—HRH1—Class A/1 (Rhodopsin-like receptors)—GRP—lung cancer	9.4e-05	0.00452	CbGpPWpGaD
Alimemazine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—ANXA1—lung cancer	9.34e-05	0.00449	CbGpPWpGaD
Alimemazine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2E1—lung cancer	9.21e-05	0.00443	CbGpPWpGaD
Alimemazine—HRH1—IL-4 Signaling Pathway—EP300—lung cancer	9.17e-05	0.00441	CbGpPWpGaD
Alimemazine—CYP3A4—Tryptophan metabolism—CAT—lung cancer	9.14e-05	0.00439	CbGpPWpGaD
Alimemazine—CYP3A4—Oxidation by Cytochrome P450—CYP2E1—lung cancer	9.09e-05	0.00437	CbGpPWpGaD
Alimemazine—CYP3A4—Biological oxidations—GSTM2—lung cancer	8.88e-05	0.00427	CbGpPWpGaD
Alimemazine—CYP3A4—Biological oxidations—CNDP2—lung cancer	8.88e-05	0.00427	CbGpPWpGaD
Alimemazine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—APP—lung cancer	8.86e-05	0.00426	CbGpPWpGaD
Alimemazine—CYP3A4—Phase 1 - Functionalization of compounds—CYP2A6—lung cancer	8.78e-05	0.00422	CbGpPWpGaD
Alimemazine—CYP3A4—Metapathway biotransformation—GSTM2—lung cancer	8.76e-05	0.00421	CbGpPWpGaD
Alimemazine—HRH1—GPCR ligand binding—GRM8—lung cancer	8.69e-05	0.00418	CbGpPWpGaD
Alimemazine—HRH1—IL-4 Signaling Pathway—STAT3—lung cancer	8.6e-05	0.00413	CbGpPWpGaD
Alimemazine—HRH1—IL-4 Signaling Pathway—MAPK3—lung cancer	8.22e-05	0.00395	CbGpPWpGaD
Alimemazine—CYP3A4—Tryptophan metabolism—CYP1A1—lung cancer	8.19e-05	0.00393	CbGpPWpGaD
Alimemazine—CYP3A4—Biological oxidations—CYP2A7—lung cancer	8.03e-05	0.00386	CbGpPWpGaD
Alimemazine—CYP3A4—Metapathway biotransformation—CYP2A7—lung cancer	7.92e-05	0.00381	CbGpPWpGaD
Alimemazine—HRH1—G alpha (q) signalling events—AVP—lung cancer	7.7e-05	0.0037	CbGpPWpGaD
Alimemazine—CYP3A4—Phase 1 - Functionalization of compounds—CYP2E1—lung cancer	7.47e-05	0.00359	CbGpPWpGaD
Alimemazine—HRH1—GPCR ligand binding—GRP—lung cancer	7.16e-05	0.00344	CbGpPWpGaD
Alimemazine—HRH1—GPCR ligand binding—OXTR—lung cancer	7.16e-05	0.00344	CbGpPWpGaD
Alimemazine—CYP3A4—Biological oxidations—GSTA3—lung cancer	7.16e-05	0.00344	CbGpPWpGaD
Alimemazine—CYP3A4—Metapathway biotransformation—GSTA3—lung cancer	7.06e-05	0.00339	CbGpPWpGaD
Alimemazine—HRH1—Class A/1 (Rhodopsin-like receptors)—ANXA1—lung cancer	6.92e-05	0.00332	CbGpPWpGaD
Alimemazine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—AVP—lung cancer	6.89e-05	0.00331	CbGpPWpGaD
Alimemazine—HRH1—IL-4 Signaling Pathway—PIK3CA—lung cancer	6.78e-05	0.00326	CbGpPWpGaD
Alimemazine—HRH1—GPCR ligand binding—GNG11—lung cancer	6.7e-05	0.00322	CbGpPWpGaD
Alimemazine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—lung cancer	6.62e-05	0.00318	CbGpPWpGaD
Alimemazine—HRH1—Class A/1 (Rhodopsin-like receptors)—APP—lung cancer	6.56e-05	0.00315	CbGpPWpGaD
Alimemazine—CYP3A4—Biological oxidations—GSTA4—lung cancer	6.55e-05	0.00315	CbGpPWpGaD
Alimemazine—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—lung cancer	6.53e-05	0.00314	CbGpPWpGaD
Alimemazine—CYP3A4—Metapathway biotransformation—GSTA4—lung cancer	6.46e-05	0.0031	CbGpPWpGaD
Alimemazine—CYP3A4—Biological oxidations—GSTA2—lung cancer	6.38e-05	0.00307	CbGpPWpGaD
Alimemazine—CYP3A4—Biological oxidations—GSTA1—lung cancer	6.16e-05	0.00296	CbGpPWpGaD
Alimemazine—CYP3A4—Metapathway biotransformation—AKR1C1—lung cancer	5.81e-05	0.00279	CbGpPWpGaD
Alimemazine—HRH1—GPCR downstream signaling—GIPR—lung cancer	5.78e-05	0.00278	CbGpPWpGaD
Alimemazine—CYP3A4—Biological oxidations—UGT1A1—lung cancer	5.72e-05	0.00275	CbGpPWpGaD
Alimemazine—CYP3A4—Metapathway biotransformation—UGT1A1—lung cancer	5.64e-05	0.00271	CbGpPWpGaD
Alimemazine—HRH1—GPCR ligand binding—PTHLH—lung cancer	5.6e-05	0.00269	CbGpPWpGaD
Alimemazine—HRH1—IL-4 Signaling Pathway—AKT1—lung cancer	5.54e-05	0.00266	CbGpPWpGaD
Alimemazine—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—lung cancer	5.37e-05	0.00258	CbGpPWpGaD
Alimemazine—HRH1—GPCR ligand binding—ANXA1—lung cancer	5.27e-05	0.00253	CbGpPWpGaD
Alimemazine—HRH1—Signaling by GPCR—GIPR—lung cancer	5.25e-05	0.00252	CbGpPWpGaD
Alimemazine—HRH1—Class A/1 (Rhodopsin-like receptors)—AVP—lung cancer	5.1e-05	0.00245	CbGpPWpGaD
Alimemazine—CYP3A4—Tryptophan metabolism—MDM2—lung cancer	5.05e-05	0.00243	CbGpPWpGaD
Alimemazine—HRH1—GPCR ligand binding—APP—lung cancer	4.99e-05	0.0024	CbGpPWpGaD
Alimemazine—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—lung cancer	4.93e-05	0.00237	CbGpPWpGaD
Alimemazine—HRH1—GPCR downstream signaling—GRM8—lung cancer	4.91e-05	0.00236	CbGpPWpGaD
Alimemazine—CYP3A4—Biological oxidations—HPGDS—lung cancer	4.87e-05	0.00234	CbGpPWpGaD
Alimemazine—CYP3A4—Biological oxidations—GSTT1—lung cancer	4.72e-05	0.00227	CbGpPWpGaD
Alimemazine—CYP3A4—Biological oxidations—GCLC—lung cancer	4.67e-05	0.00224	CbGpPWpGaD
Alimemazine—CYP3A4—Biological oxidations—CYP2A6—lung cancer	4.67e-05	0.00224	CbGpPWpGaD
Alimemazine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6R—lung cancer	4.46e-05	0.00215	CbGpPWpGaD
Alimemazine—HRH1—Signaling by GPCR—GRM8—lung cancer	4.46e-05	0.00214	CbGpPWpGaD
Alimemazine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—MAP2K1—lung cancer	4.25e-05	0.00204	CbGpPWpGaD
Alimemazine—HRH1—Signaling Pathways—AXL—lung cancer	4.09e-05	0.00197	CbGpPWpGaD
Alimemazine—HRH1—GPCR downstream signaling—OXTR—lung cancer	4.05e-05	0.00194	CbGpPWpGaD
Alimemazine—HRH1—GPCR downstream signaling—GRP—lung cancer	4.05e-05	0.00194	CbGpPWpGaD
Alimemazine—CYP3A4—Phase 1 - Functionalization of compounds—POMC—lung cancer	4e-05	0.00192	CbGpPWpGaD
Alimemazine—CYP3A4—Biological oxidations—CYP2E1—lung cancer	3.97e-05	0.00191	CbGpPWpGaD
Alimemazine—CYP3A4—Metapathway biotransformation—CYP2E1—lung cancer	3.91e-05	0.00188	CbGpPWpGaD
Alimemazine—HRH1—GPCR ligand binding—AVP—lung cancer	3.88e-05	0.00187	CbGpPWpGaD
Alimemazine—HRH1—GPCR downstream signaling—GNG11—lung cancer	3.79e-05	0.00182	CbGpPWpGaD
Alimemazine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—RAF1—lung cancer	3.77e-05	0.00181	CbGpPWpGaD
Alimemazine—HRH1—Signaling by GPCR—GRP—lung cancer	3.67e-05	0.00177	CbGpPWpGaD
Alimemazine—HRH1—Signaling by GPCR—OXTR—lung cancer	3.67e-05	0.00177	CbGpPWpGaD
Alimemazine—HRH1—Signaling by GPCR—GNG11—lung cancer	3.44e-05	0.00165	CbGpPWpGaD
Alimemazine—HRH1—GPCR downstream signaling—ADCY1—lung cancer	3.41e-05	0.00164	CbGpPWpGaD
Alimemazine—HRH1—Class A/1 (Rhodopsin-like receptors)—POMC—lung cancer	3.39e-05	0.00163	CbGpPWpGaD
Alimemazine—CYP3A4—Biological oxidations—GSTP1—lung cancer	3.27e-05	0.00157	CbGpPWpGaD
Alimemazine—CYP3A4—Metapathway biotransformation—GSTP1—lung cancer	3.23e-05	0.00155	CbGpPWpGaD
Alimemazine—HRH1—Signaling Pathways—COL4A2—lung cancer	3.18e-05	0.00153	CbGpPWpGaD
Alimemazine—HRH1—GPCR downstream signaling—PTHLH—lung cancer	3.17e-05	0.00152	CbGpPWpGaD
Alimemazine—HRH1—Signaling Pathways—GIPR—lung cancer	3.1e-05	0.00149	CbGpPWpGaD
Alimemazine—HRH1—Signaling by GPCR—ADCY1—lung cancer	3.09e-05	0.00149	CbGpPWpGaD
Alimemazine—HRH1—Signaling by GPCR—PPP2R1B—lung cancer	3.01e-05	0.00145	CbGpPWpGaD
Alimemazine—CYP3A4—Biological oxidations—GSTM1—lung cancer	3.01e-05	0.00144	CbGpPWpGaD
Alimemazine—HRH1—GPCR downstream signaling—ANXA1—lung cancer	2.98e-05	0.00143	CbGpPWpGaD
Alimemazine—CYP3A4—Metapathway biotransformation—GSTM1—lung cancer	2.97e-05	0.00143	CbGpPWpGaD
Alimemazine—HRH1—Signaling Pathways—SDC4—lung cancer	2.89e-05	0.00139	CbGpPWpGaD
Alimemazine—HRH1—Signaling by GPCR—PTHLH—lung cancer	2.88e-05	0.00138	CbGpPWpGaD
Alimemazine—CYP3A4—Biological oxidations—CYP1A1—lung cancer	2.85e-05	0.00137	CbGpPWpGaD
Alimemazine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—NRAS—lung cancer	2.84e-05	0.00136	CbGpPWpGaD
Alimemazine—HRH1—Signaling Pathways—DUSP3—lung cancer	2.84e-05	0.00136	CbGpPWpGaD
Alimemazine—HRH1—GPCR downstream signaling—APP—lung cancer	2.82e-05	0.00136	CbGpPWpGaD
Alimemazine—CYP3A4—Metapathway biotransformation—CYP1A1—lung cancer	2.81e-05	0.00135	CbGpPWpGaD
Alimemazine—HRH1—Signaling Pathways—RHEB—lung cancer	2.78e-05	0.00134	CbGpPWpGaD
Alimemazine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—MAPK3—lung cancer	2.72e-05	0.00131	CbGpPWpGaD
Alimemazine—HRH1—Signaling by GPCR—ANXA1—lung cancer	2.7e-05	0.0013	CbGpPWpGaD
Alimemazine—HRH1—Signaling Pathways—GRM8—lung cancer	2.64e-05	0.00127	CbGpPWpGaD
Alimemazine—HRH1—Class A/1 (Rhodopsin-like receptors)—CXCL8—lung cancer	2.62e-05	0.00126	CbGpPWpGaD
Alimemazine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—lung cancer	2.59e-05	0.00124	CbGpPWpGaD
Alimemazine—HRH1—GPCR ligand binding—POMC—lung cancer	2.58e-05	0.00124	CbGpPWpGaD
Alimemazine—HRH1—Signaling by GPCR—APP—lung cancer	2.56e-05	0.00123	CbGpPWpGaD
Alimemazine—HRH1—Signaling Pathways—SKI—lung cancer	2.55e-05	0.00123	CbGpPWpGaD
Alimemazine—HRH1—G alpha (q) signalling events—PIK3CA—lung cancer	2.51e-05	0.00121	CbGpPWpGaD
Alimemazine—CYP3A4—Metabolism—COL4A3BP—lung cancer	2.51e-05	0.0012	CbGpPWpGaD
Alimemazine—CYP3A4—Metabolism—AZIN2—lung cancer	2.51e-05	0.0012	CbGpPWpGaD
Alimemazine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—KRAS—lung cancer	2.44e-05	0.00117	CbGpPWpGaD
Alimemazine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—PIK3CA—lung cancer	2.25e-05	0.00108	CbGpPWpGaD
Alimemazine—HRH1—Signaling Pathways—PXN—lung cancer	2.22e-05	0.00107	CbGpPWpGaD
Alimemazine—HRH1—GPCR downstream signaling—AVP—lung cancer	2.19e-05	0.00105	CbGpPWpGaD
Alimemazine—HRH1—Signaling Pathways—GRP—lung cancer	2.17e-05	0.00104	CbGpPWpGaD
Alimemazine—HRH1—Signaling Pathways—OXTR—lung cancer	2.17e-05	0.00104	CbGpPWpGaD
Alimemazine—HRH1—Signaling Pathways—AKR1C1—lung cancer	2.17e-05	0.00104	CbGpPWpGaD
Alimemazine—CYP3A4—Metabolism—ATP5H—lung cancer	2.13e-05	0.00102	CbGpPWpGaD
Alimemazine—CYP3A4—Biological oxidations—POMC—lung cancer	2.13e-05	0.00102	CbGpPWpGaD
Alimemazine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—lung cancer	2.08e-05	0.000999	CbGpPWpGaD
Alimemazine—HRH1—Signaling Pathways—GNG11—lung cancer	2.03e-05	0.000976	CbGpPWpGaD
Alimemazine—HRH1—GPCR ligand binding—CXCL8—lung cancer	2e-05	0.000959	CbGpPWpGaD
Alimemazine—HRH1—Signaling by GPCR—AVP—lung cancer	1.99e-05	0.000958	CbGpPWpGaD
Alimemazine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—lung cancer	1.99e-05	0.000956	CbGpPWpGaD
Alimemazine—HRH1—Signaling Pathways—VEGFC—lung cancer	1.93e-05	0.00093	CbGpPWpGaD
Alimemazine—CYP3A4—Metabolism—PLBD1—lung cancer	1.9e-05	0.000913	CbGpPWpGaD
Alimemazine—HRH1—Signaling Pathways—ADCY1—lung cancer	1.83e-05	0.000878	CbGpPWpGaD
Alimemazine—HRH1—Signaling Pathways—SMARCA4—lung cancer	1.78e-05	0.000856	CbGpPWpGaD
Alimemazine—HRH1—Signaling Pathways—PPP2R1B—lung cancer	1.78e-05	0.000856	CbGpPWpGaD
Alimemazine—CYP3A4—Metabolism—HSD17B10—lung cancer	1.74e-05	0.000835	CbGpPWpGaD
Alimemazine—HRH1—Signaling Pathways—HSPB1—lung cancer	1.72e-05	0.000825	CbGpPWpGaD
Alimemazine—HRH1—Signaling Pathways—PTHLH—lung cancer	1.7e-05	0.000816	CbGpPWpGaD
Alimemazine—CYP3A4—Metabolism—CKB—lung cancer	1.62e-05	0.000776	CbGpPWpGaD
Alimemazine—HRH1—Signaling Pathways—ANXA1—lung cancer	1.6e-05	0.000767	CbGpPWpGaD
Alimemazine—HRH1—Signaling Pathways—FLT1—lung cancer	1.55e-05	0.000743	CbGpPWpGaD
Alimemazine—HRH1—GPCR downstream signaling—PIK3CG—lung cancer	1.53e-05	0.000736	CbGpPWpGaD
Alimemazine—CYP3A4—Metabolism—CNDP2—lung cancer	1.52e-05	0.00073	CbGpPWpGaD
Alimemazine—CYP3A4—Metabolism—GSTM2—lung cancer	1.52e-05	0.00073	CbGpPWpGaD
Alimemazine—HRH1—Signaling Pathways—APP—lung cancer	1.51e-05	0.000728	CbGpPWpGaD
Alimemazine—HRH1—Signaling Pathways—NOTCH3—lung cancer	1.51e-05	0.000728	CbGpPWpGaD
Alimemazine—HRH1—Signaling Pathways—FGF9—lung cancer	1.5e-05	0.000722	CbGpPWpGaD
Alimemazine—CYP3A4—Metabolism—MTMR3—lung cancer	1.48e-05	0.00071	CbGpPWpGaD
Alimemazine—HRH1—GPCR downstream signaling—POMC—lung cancer	1.46e-05	0.000701	CbGpPWpGaD
Alimemazine—CYP3A4—Metabolism—PGAM1—lung cancer	1.44e-05	0.000692	CbGpPWpGaD
Alimemazine—HRH1—Signaling Pathways—JUNB—lung cancer	1.43e-05	0.000689	CbGpPWpGaD
Alimemazine—HRH1—Signaling by GPCR—PIK3CG—lung cancer	1.39e-05	0.000669	CbGpPWpGaD
Alimemazine—CYP3A4—Metabolism—CYP2A7—lung cancer	1.37e-05	0.00066	CbGpPWpGaD
Alimemazine—HRH1—GPCR downstream signaling—PIK3CD—lung cancer	1.35e-05	0.000647	CbGpPWpGaD
Alimemazine—CYP3A4—Metabolism—SDC4—lung cancer	1.34e-05	0.000646	CbGpPWpGaD
Alimemazine—HRH1—Signaling by GPCR—POMC—lung cancer	1.32e-05	0.000636	CbGpPWpGaD
Alimemazine—HRH1—Signaling Pathways—STK11—lung cancer	1.3e-05	0.000626	CbGpPWpGaD
Alimemazine—HRH1—Signaling by GPCR—IL6R—lung cancer	1.29e-05	0.000621	CbGpPWpGaD
Alimemazine—HRH1—Signaling Pathways—FOXO3—lung cancer	1.26e-05	0.000604	CbGpPWpGaD
Alimemazine—HRH1—Signaling by GPCR—MAP2K1—lung cancer	1.23e-05	0.000592	CbGpPWpGaD
Alimemazine—CYP3A4—Metabolism—GSTA3—lung cancer	1.22e-05	0.000588	CbGpPWpGaD
Alimemazine—CYP3A4—Metabolism—RRM1—lung cancer	1.22e-05	0.000588	CbGpPWpGaD
Alimemazine—HRH1—Signaling by GPCR—PIK3CD—lung cancer	1.22e-05	0.000588	CbGpPWpGaD
Alimemazine—HRH1—Signaling Pathways—AVP—lung cancer	1.18e-05	0.000566	CbGpPWpGaD
Alimemazine—HRH1—GPCR downstream signaling—PIK3CB—lung cancer	1.17e-05	0.000564	CbGpPWpGaD
Alimemazine—CYP3A4—Metabolism—B4GALT5—lung cancer	1.15e-05	0.000553	CbGpPWpGaD
Alimemazine—HRH1—Signaling Pathways—IGF1R—lung cancer	1.13e-05	0.000545	CbGpPWpGaD
Alimemazine—HRH1—GPCR downstream signaling—CXCL8—lung cancer	1.13e-05	0.000542	CbGpPWpGaD
Alimemazine—CYP3A4—Metabolism—GSTA4—lung cancer	1.12e-05	0.000538	CbGpPWpGaD
Alimemazine—HRH1—Signaling Pathways—HES1—lung cancer	1.11e-05	0.000535	CbGpPWpGaD
Alimemazine—HRH1—Signaling by GPCR—RAF1—lung cancer	1.09e-05	0.000525	CbGpPWpGaD
Alimemazine—CYP3A4—Metabolism—GSTA2—lung cancer	1.09e-05	0.000524	CbGpPWpGaD
Alimemazine—HRH1—GPCR downstream signaling—IL2—lung cancer	1.08e-05	0.000518	CbGpPWpGaD
Alimemazine—HRH1—Signaling by GPCR—PIK3CB—lung cancer	1.07e-05	0.000512	CbGpPWpGaD
Alimemazine—CYP3A4—Metabolism—GSTA1—lung cancer	1.05e-05	0.000506	CbGpPWpGaD
Alimemazine—CYP3A4—Metabolism—ABCC3—lung cancer	1.04e-05	0.0005	CbGpPWpGaD
Alimemazine—HRH1—Signaling by GPCR—CXCL8—lung cancer	1.02e-05	0.000492	CbGpPWpGaD
Alimemazine—HRH1—Signaling Pathways—ERBB3—lung cancer	1.02e-05	0.000489	CbGpPWpGaD
Alimemazine—CYP3A4—Metabolism—AKR1C1—lung cancer	1.01e-05	0.000485	CbGpPWpGaD
Alimemazine—HRH1—Signaling by GPCR—IL2—lung cancer	9.79e-06	0.000471	CbGpPWpGaD
Alimemazine—CYP3A4—Metabolism—UGT1A1—lung cancer	9.79e-06	0.00047	CbGpPWpGaD
Alimemazine—HRH1—Signaling Pathways—TERT—lung cancer	9.75e-06	0.000469	CbGpPWpGaD
Alimemazine—HRH1—Signaling Pathways—FGFR1—lung cancer	9.47e-06	0.000455	CbGpPWpGaD
Alimemazine—CYP3A4—Metabolism—GNG11—lung cancer	9.44e-06	0.000454	CbGpPWpGaD
Alimemazine—HRH1—Signaling Pathways—HIF1A—lung cancer	9.33e-06	0.000448	CbGpPWpGaD
Alimemazine—HRH1—Signaling Pathways—APOA1—lung cancer	9e-06	0.000433	CbGpPWpGaD
Alimemazine—CYP3A4—Metabolism—ALDOA—lung cancer	8.99e-06	0.000432	CbGpPWpGaD
Alimemazine—HRH1—Signaling Pathways—KDR—lung cancer	8.92e-06	0.000429	CbGpPWpGaD
Alimemazine—CYP3A4—Metabolism—NCOA3—lung cancer	8.72e-06	0.000419	CbGpPWpGaD
Alimemazine—CYP3A4—Metabolism—ABCG2—lung cancer	8.49e-06	0.000408	CbGpPWpGaD
Alimemazine—CYP3A4—Metabolism—ADCY1—lung cancer	8.49e-06	0.000408	CbGpPWpGaD
Alimemazine—CYP3A4—Metabolism—HPGDS—lung cancer	8.32e-06	0.0004	CbGpPWpGaD
Alimemazine—CYP3A4—Metabolism—ENO2—lung cancer	8.32e-06	0.0004	CbGpPWpGaD
Alimemazine—CYP3A4—Metabolism—PPP2R1B—lung cancer	8.27e-06	0.000397	CbGpPWpGaD
Alimemazine—HRH1—Signaling Pathways—APC—lung cancer	8.22e-06	0.000395	CbGpPWpGaD
Alimemazine—HRH1—Signaling Pathways—PIK3CG—lung cancer	8.22e-06	0.000395	CbGpPWpGaD
Alimemazine—HRH1—Signaling Pathways—KIT—lung cancer	8.22e-06	0.000395	CbGpPWpGaD
Alimemazine—HRH1—Signaling by GPCR—NRAS—lung cancer	8.22e-06	0.000395	CbGpPWpGaD
Alimemazine—HRH1—Signaling Pathways—EGF—lung cancer	8.12e-06	0.00039	CbGpPWpGaD
Alimemazine—CYP3A4—Metabolism—GSTT1—lung cancer	8.07e-06	0.000388	CbGpPWpGaD
Alimemazine—CYP3A4—Metabolism—CYP2A6—lung cancer	7.98e-06	0.000383	CbGpPWpGaD
Alimemazine—CYP3A4—Metabolism—GCLC—lung cancer	7.98e-06	0.000383	CbGpPWpGaD
Alimemazine—HRH1—Signaling by GPCR—MAPK3—lung cancer	7.87e-06	0.000378	CbGpPWpGaD
Alimemazine—HRH1—Signaling Pathways—POMC—lung cancer	7.82e-06	0.000376	CbGpPWpGaD
Alimemazine—HRH1—Signaling Pathways—BRAF—lung cancer	7.73e-06	0.000371	CbGpPWpGaD
Alimemazine—HRH1—Signaling Pathways—IL6R—lung cancer	7.63e-06	0.000367	CbGpPWpGaD
Alimemazine—HRH1—Signaling Pathways—CREBBP—lung cancer	7.62e-06	0.000366	CbGpPWpGaD
Alimemazine—CYP3A4—Metabolism—ENO1—lung cancer	7.56e-06	0.000364	CbGpPWpGaD
Alimemazine—HRH1—Signaling by GPCR—EGFR—lung cancer	7.49e-06	0.00036	CbGpPWpGaD
Alimemazine—HRH1—Signaling Pathways—MAP2K1—lung cancer	7.27e-06	0.00035	CbGpPWpGaD
Alimemazine—HRH1—Signaling Pathways—PIK3CD—lung cancer	7.23e-06	0.000347	CbGpPWpGaD
Alimemazine—HRH1—GPCR downstream signaling—PIK3CA—lung cancer	7.16e-06	0.000344	CbGpPWpGaD
Alimemazine—HRH1—Signaling by GPCR—KRAS—lung cancer	7.07e-06	0.00034	CbGpPWpGaD
Alimemazine—CYP3A4—Metabolism—CYP2E1—lung cancer	6.78e-06	0.000326	CbGpPWpGaD
Alimemazine—CYP3A4—Metabolism—NQO1—lung cancer	6.71e-06	0.000322	CbGpPWpGaD
Alimemazine—HRH1—Signaling by GPCR—PIK3CA—lung cancer	6.5e-06	0.000312	CbGpPWpGaD
Alimemazine—HRH1—Signaling Pathways—MDM2—lung cancer	6.47e-06	0.000311	CbGpPWpGaD
Alimemazine—HRH1—Signaling Pathways—RAF1—lung cancer	6.45e-06	0.00031	CbGpPWpGaD
Alimemazine—HRH1—Signaling Pathways—ERBB2—lung cancer	6.38e-06	0.000307	CbGpPWpGaD
Alimemazine—HRH1—Signaling Pathways—PIK3CB—lung cancer	6.3e-06	0.000303	CbGpPWpGaD
Alimemazine—HRH1—Signaling Pathways—MTOR—lung cancer	6.3e-06	0.000303	CbGpPWpGaD
Alimemazine—HRH1—Signaling Pathways—CXCL8—lung cancer	6.05e-06	0.000291	CbGpPWpGaD
Alimemazine—CYP3A4—Metabolism—STK11—lung cancer	6.05e-06	0.000291	CbGpPWpGaD
Alimemazine—HRH1—Signaling by GPCR—HRAS—lung cancer	6.01e-06	0.000289	CbGpPWpGaD
Alimemazine—HRH1—GPCR downstream signaling—AKT1—lung cancer	5.85e-06	0.000281	CbGpPWpGaD
Alimemazine—HRH1—Signaling Pathways—CASP3—lung cancer	5.79e-06	0.000278	CbGpPWpGaD
Alimemazine—HRH1—Signaling Pathways—IL2—lung cancer	5.78e-06	0.000278	CbGpPWpGaD
Alimemazine—HRH1—Signaling by GPCR—IL6—lung cancer	5.75e-06	0.000277	CbGpPWpGaD
Alimemazine—HRH1—Signaling Pathways—CCND1—lung cancer	5.64e-06	0.000271	CbGpPWpGaD
Alimemazine—HRH1—Signaling Pathways—JUN—lung cancer	5.63e-06	0.00027	CbGpPWpGaD
Alimemazine—CYP3A4—Metabolism—GSTP1—lung cancer	5.6e-06	0.000269	CbGpPWpGaD
Alimemazine—HRH1—Signaling Pathways—MMP9—lung cancer	5.47e-06	0.000263	CbGpPWpGaD
Alimemazine—HRH1—Signaling Pathways—CDKN1A—lung cancer	5.45e-06	0.000262	CbGpPWpGaD
Alimemazine—CYP3A4—Metabolism—CAT—lung cancer	5.44e-06	0.000262	CbGpPWpGaD
Alimemazine—HRH1—Signaling Pathways—PTEN—lung cancer	5.44e-06	0.000262	CbGpPWpGaD
Alimemazine—HRH1—Signaling by GPCR—AKT1—lung cancer	5.31e-06	0.000255	CbGpPWpGaD
Alimemazine—CYP3A4—Metabolism—ABCB1—lung cancer	5.3e-06	0.000255	CbGpPWpGaD
Alimemazine—CYP3A4—Metabolism—TYMS—lung cancer	5.2e-06	0.00025	CbGpPWpGaD
Alimemazine—HRH1—Signaling Pathways—EP300—lung cancer	5.19e-06	0.000249	CbGpPWpGaD
Alimemazine—CYP3A4—Metabolism—GSTM1—lung cancer	5.14e-06	0.000247	CbGpPWpGaD
Alimemazine—HRH1—Signaling Pathways—SRC—lung cancer	5.05e-06	0.000243	CbGpPWpGaD
Alimemazine—HRH1—Signaling Pathways—VEGFA—lung cancer	4.92e-06	0.000236	CbGpPWpGaD
Alimemazine—CYP3A4—Metabolism—CYP1A1—lung cancer	4.87e-06	0.000234	CbGpPWpGaD
Alimemazine—HRH1—Signaling Pathways—STAT3—lung cancer	4.87e-06	0.000234	CbGpPWpGaD
Alimemazine—HRH1—Signaling Pathways—NRAS—lung cancer	4.86e-06	0.000233	CbGpPWpGaD
Alimemazine—CYP3A4—Metabolism—ERCC2—lung cancer	4.83e-06	0.000232	CbGpPWpGaD
Alimemazine—HRH1—Signaling Pathways—MAPK3—lung cancer	4.65e-06	0.000223	CbGpPWpGaD
Alimemazine—HRH1—Signaling Pathways—MYC—lung cancer	4.52e-06	0.000217	CbGpPWpGaD
Alimemazine—HRH1—Signaling Pathways—EGFR—lung cancer	4.42e-06	0.000213	CbGpPWpGaD
Alimemazine—CYP3A4—Metabolism—APOA1—lung cancer	4.18e-06	0.000201	CbGpPWpGaD
Alimemazine—HRH1—Signaling Pathways—KRAS—lung cancer	4.18e-06	0.000201	CbGpPWpGaD
Alimemazine—HRH1—Signaling Pathways—PIK3CA—lung cancer	3.84e-06	0.000184	CbGpPWpGaD
Alimemazine—CYP3A4—Metabolism—PIK3CG—lung cancer	3.82e-06	0.000183	CbGpPWpGaD
Alimemazine—HRH1—Signaling Pathways—TP53—lung cancer	3.71e-06	0.000178	CbGpPWpGaD
Alimemazine—CYP3A4—Metabolism—POMC—lung cancer	3.63e-06	0.000175	CbGpPWpGaD
Alimemazine—HRH1—Signaling Pathways—HRAS—lung cancer	3.55e-06	0.000171	CbGpPWpGaD
Alimemazine—CYP3A4—Metabolism—CREBBP—lung cancer	3.54e-06	0.00017	CbGpPWpGaD
Alimemazine—HRH1—Signaling Pathways—IL6—lung cancer	3.4e-06	0.000163	CbGpPWpGaD
Alimemazine—CYP3A4—Metabolism—PIK3CD—lung cancer	3.36e-06	0.000161	CbGpPWpGaD
Alimemazine—CYP3A4—Metabolism—ALB—lung cancer	3.31e-06	0.000159	CbGpPWpGaD
Alimemazine—HRH1—Signaling Pathways—AKT1—lung cancer	3.14e-06	0.000151	CbGpPWpGaD
Alimemazine—CYP3A4—Metabolism—PIK3CB—lung cancer	2.93e-06	0.000141	CbGpPWpGaD
Alimemazine—CYP3A4—Metabolism—PTGS2—lung cancer	2.9e-06	0.000139	CbGpPWpGaD
Alimemazine—CYP3A4—Metabolism—PTEN—lung cancer	2.53e-06	0.000121	CbGpPWpGaD
Alimemazine—CYP3A4—Metabolism—EP300—lung cancer	2.41e-06	0.000116	CbGpPWpGaD
Alimemazine—CYP3A4—Metabolism—PIK3CA—lung cancer	1.78e-06	8.57e-05	CbGpPWpGaD
Alimemazine—CYP3A4—Metabolism—AKT1—lung cancer	1.46e-06	7e-05	CbGpPWpGaD
